Serum IL-1β, sIL-2R, IL-6, IL-8 and TNF-α in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment

Mediators of Inflammation

Volumn 10, Issue 3, 2001, Pages 109-115

  Erbagci A B ^a   Herken, H ^a   Koyluoglu O ^a   Yilmaz, N ^a   Tarakcioglu M ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Interleukins; Risperidone; Schizophrenia; Tumour necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; RISPERIDONE; TUMOR NECROSIS FACTOR ALPHA; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 1; NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; IMMUNOMODULATION; INFLAMMATION; MALE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SCHIZOPHRENIA; SYMPTOMATOLOGY; BLOOD; BRIEF PSYCHIATRIC RATING SCALE; CASE CONTROL STUDY; IMMUNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; BRIEF PSYCHIATRIC RATING SCALE; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; RISPERIDONE; SCHIZOPHRENIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034742546     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629350123895     Document Type: Article

References (32)

1. Cytokines and the brain: Implications for clinical psychiatry
2. Polymorphisms of the interleukin-1 gene complex in schizophrenia
3. Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment
4. Increased soluble interleukin 2 receptor levels in schizophrenia
5. Cytokines in affective disorders and schizophrenia: New clinical and genetic findings
6. Cytokines
7. Interleukin-2 and -6 induce behavioral-activating effects in mice
8. Cytokines production in chronic schizophrenia patients with or without paranoid behaviour
9. Treatment-resistant schizophrenia
10. Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia
11. Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: Effects of antipsychotic drugs
12. The brief psychiatric rating scale
13. Decreased interleukin-2 production in schizophrenic patients
14. Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. The influence of age at onset and negative symptoms
15. Aberrant T cell-mediated immunity in untreated schizophrenic patients: Deficient interleukin-2 production
16. Increased serum interleukin 2 receptor concentration in schizophrenic and brain-damaged subjects
17. Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression
18. Serum cytokine concentrations in patients with schizophrenia
19. Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients
20. A differential role for interleukin-6 and tumor necrosis factor-α in schizophrenia?
21. Elevated interleukin-6 in schizophrenia
22. The inflammatory response system in treatment-resistant schizophrenia: Increased serum interleukin-6
23. Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics
24. Serum interleukin-6 in schizophrenic patients
25. Changes of plasma concentrations of interleukin-1α and interleukin-6 with neuroleptic treatment for schizophrenia
26. Changes in interleukin-1β and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients
27. Interleukins 1,2 and 6 in the plasma of neuroleptic-free and treated schizophrenic patients and their relatives
28. Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: Effects of clozapine treatment
29. Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers
30. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: Effects of confounding factors and diagnosis
31. Vivo immunomodulatory effects of clozapine in schizophrenia
32. Cytokine production in unmedicated and treated schizophrenic patients